InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,958.40
(
0.00%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.18
(
-0.11%
)
Bitcoin
61,146.25
(
1.47%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 120
Posts 20685
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: None

Tuesday, 11/28/2023 11:45:03 AM

Tuesday, November 28, 2023 11:45:03 AM

Post# of 252337
CABA

. FDA is investigating reports of T-cell malignancies, including chimeric antigen receptor (CAR) positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T-cell immunotherapies. https://fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous



I hate investing in biotech :--)
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up